Discovery of TAK-960: An orally available small molecule inhibitor of polo-like kinase 1 (PLK1).

MLA

Nie, Zhe, et al. “Discovery of TAK-960: An Orally Available Small Molecule Inhibitor of Polo-like Kinase 1 (PLK1).” Bioorganic & Medicinal Chemistry Letters, vol. 23, no. 12, June 2013, pp. 3662–66. EBSCOhost, https://doi.org/10.1016/j.bmcl.2013.02.083.

APA

Nie, Z., Feher, V., Natala, S., McBride, C., Kiryanov, A., Jones, B., Lam, B., Liu, Y., Kaldor, S., Stafford, J., Hikami, K., Uchiyama, N., Kawamoto, T., Hikichi, Y., Matsumoto, S., Amano, N., Zhang, L., Hosfield, D., Skene, R., & Zou, H. (2013). Discovery of TAK-960: An orally available small molecule inhibitor of polo-like kinase 1 (PLK1). Bioorganic & Medicinal Chemistry Letters, 23(12), 3662–3666. https://doi.org/10.1016/j.bmcl.2013.02.083

Chicago

Nie, Zhe, Victoria Feher, Srinivasa Natala, Christopher McBride, Andre Kiryanov, Benjamin Jones, Betty Lam, et al. 2013. “Discovery of TAK-960: An Orally Available Small Molecule Inhibitor of Polo-like Kinase 1 (PLK1).” Bioorganic & Medicinal Chemistry Letters 23 (12): 3662–66. doi:10.1016/j.bmcl.2013.02.083.